Avricore Health Inc.
AVCR.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,619.61% | -24,328.57% | -156.44% | 8.83% | 110.32% |
| Total Depreciation and Amortization | -50.34% | -35.81% | -17.14% | 6.95% | 27.21% |
| Total Amortization of Deferred Charges | 62.90% | 19.35% | -22.58% | -59.68% | 24.00% |
| Total Other Non-Cash Items | 135.45% | 209.85% | 109.25% | 82.78% | -38.55% |
| Change in Net Operating Assets | 103.05% | 96.36% | -116.60% | -146.09% | -177.36% |
| Cash from Operations | -117.32% | -55.12% | -18.91% | 49.97% | 131.26% |
| Capital Expenditure | 83.47% | 80.98% | 81.02% | 82.39% | 53.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.46% | 22.71% | -9.57% | 5.35% | -96.18% |
| Cash from Investing | 79.43% | 78.35% | 78.19% | 80.53% | 51.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -74.67% | 321.69% | 132.03% | 103.76% | -73.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.14% | 610.00% | 10,240.00% | 30.16% | -84.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.76% | 239.84% | 823.31% | 344.93% | 181.51% |